Health-economic modelling for diabetes mellitus

被引:0
|
作者
Stollenwerk, B. [1 ]
Becker, C. [1 ,3 ]
Leidl, R. [1 ,2 ,3 ]
机构
[1] Helmholtz Zentrum Munchen, Inst Gesundheitsokon & Management Gesundheitswese, D-85758 Neuherberg, Germany
[2] Univ Munich, Fak Betriebswirtschaft, Lehrstuhl Gesundheitsokon & Management Gesundheit, D-80539 Munich, Germany
[3] Univ Munich, Munchner Zentrum Gesundheitswissensch, D-80539 Munich, Germany
来源
DIABETOLOGE | 2011年 / 7卷 / 02期
关键词
Health-economic evaluation; Decision-analytic modelling; Markov model; Discrete event simulation; Decision tree;
D O I
10.1007/s11428-010-0640-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years health economic evaluation has gained considerable importance, also in the field of diabetes mellitus. There are a great number of decision-analytic models which are used to estimate the consequences of various intervention strategies. The aim of this article is to facilitate understanding of diabetes models. The main features of decision-analytic modelling and its use in diabetes mellitus are explained. The most basic model types, i.e. the decision tree, the Markov model and the discrete event simulation are described and differences between cohort simulation and microsimulation are explained. Furthermore, types of uncertainty in decision analysis modelling and ways to handle these are presented and specific features of the complex diabetes modelling are highlighted. Cooperation between clinicians and modellers is an important prerequisite for adequate construction and use of modelling approaches.
引用
下载
收藏
页码:99 / 104
页数:6
相关论文
共 50 条
  • [31] The health-economic models: practical aspects and management of uncertainty
    Iannazzo, Sergio
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2006, 7 (04) : 239 - 245
  • [32] The transferability of international economic health-economic results to national study questions
    Wolfgang Greiner
    Oliver Schöffski
    J.-Matthias Graf v. d. Schulenburg
    HEPAC Health Economics in Prevention and Care, 2000, 1 (2): : 94 - 102
  • [33] Health-economic analysis of the treatment of osteoporosis with risedronate.
    Brecht, JG
    Kruse, H
    Felsenberg, D
    Möhrke, W
    Oestreich, A
    Huppertz, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S160 - S160
  • [34] Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting
    van der Pol, Simon
    Garcia, Paula Rojas
    Villar, Fernando Antonanzas
    Postma, Maarten J.
    van Asselt, Antoinette D., I
    PHARMACOECONOMICS, 2021, 39 (12) : 1355 - 1363
  • [35] Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes
    Roze, S.
    Saunders, R.
    Brandt, A. -S.
    de Portu, S.
    Papo, N. L.
    Jendle, J.
    DIABETIC MEDICINE, 2015, 32 (05) : 618 - 626
  • [36] Health economic evaluation of interventions for diabetes mellitus and comorbid depression
    Chernyak, N.
    Icks, A.
    Scheer, M.
    Giani, G.
    DIABETOLOGE, 2011, 7 (02): : 88 - 91
  • [37] MARKOV MODEL FOR HEALTH-ECONOMIC EVALUATIONS OF COPD IN GERMANY
    Menn, P.
    Holle, R.
    VALUE IN HEALTH, 2009, 12 (07) : A303 - A303
  • [38] Health-economic implications of the onset of action of antimanic agents
    Keck, PE
    McElroy, SL
    Bennett, JA
    JOURNAL OF CLINICAL PSYCHIATRY, 1996, 57 : 13 - 22
  • [39] Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis
    Whittles, Lilith K.
    Didelot, Xavier
    White, Peter J.
    LANCET INFECTIOUS DISEASES, 2022, 22 (07): : 1030 - 1041
  • [40] Neurobiological, psychopathological and health-economic aspects of conduct disorder
    Vloet, Timo
    Bachmann, Christian
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S33 - S33